Enhance surveillance and rapid response capabilities for emerging infectious diseases.
Pandemics
Pandemics Risk
Assessment for this date
Today's pandemic risk is moderate due to ongoing challenges with COVID-19 variants, vaccine hesitancy, and concurrent outbreaks of other infectious diseases.
April 29, 2026
Trend
Viewing the record for April 29, 2026 within the full trend.
Risk Drivers
What is pushing the current reading.
The current pandemic risk is elevated by several factors: the emergence of new COVID-19 strains and the ongoing impact of long COVID, as evidenced by studies linking it to severe health outcomes and economic burdens. Vaccine hesitancy continues to be a significant issue, with misinformation affecting public health responses and vaccine uptake. Concurrently, there are ongoing outbreaks of other infectious diseases such as avian flu and MERS, which highlight the need for robust surveillance and response systems. Additionally, the CDC's delay in publishing vaccine efficacy reports and the divergent vaccine policies across US states suggest gaps in public health communication and coordination, further complicating pandemic management efforts.
Risk Reduction Actions
Priority actions generated from the current analysis.
Increase efforts to combat misinformation and improve public trust in vaccines.
Focus on educating patients about the benefits of vaccination and addressing vaccine hesitancy.
Accelerate the development and deployment of vaccines for multiple infectious diseases.
Strengthen global cooperation to monitor and respond to cross-border health threats.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- The State of US Vaccine Policy — Apr 28, 2026
- CDC blocks publication of report showing COVID vaccine efficacy
- COVID vaccines tied to less hospital care, long COVID, and economic burden
- Quick takes: Re-emergent COVID strain, extended US RSV season, typhus in California
- COVID vaccine may boost antibody response to MERS, other coronaviruses
- Vaccine skepticism now the norm for many Americans